Press release
Estrogen and Progesterone Market Trends, Business Overview, Industry Growth and Forecast to 2028
The global estrogen and progesterone market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). Estrogen is a female reproductive hormone that plays an important role in women to promote secondary sexual characteristics such as pubic hair, breast growth. Estrogen also plays a role in mental health, cardiovascular health. Although, progesterone is a steroid hormone that is naturally produced and produced by the placenta, ovaries, etc. Progesterone plays an important role in , reproductive health, and embryogenesis. The increasing prevalence of disorders such as amenorrhea, abnormal uterine bleeding, uterine cancer are creating demand for estrogen and progesterone market.An increasing number of women in brackets aged 45-59 are expected to boost the overall market growth. Synthetic progesterone is re-used as a diagnostic tool to assess the effects of estrogen due to technological advances in the medical industry. In hormone replacement therapy, it is used with estrogen. Increasing demand for hormone replacement therapy to treat post-menopausal problems among women is one of the key factors contributing to market growth. In addition, an increase in the number of adults with hormonal imbalances leads to the need for hormone replacement therapy. Additionally, increased awareness of hormone replacement therapy, especially in developing countries, is boosting the market growth. However, hormone replacement therapy has a higher risk of developing breast cancer among women, which hampers market growth in the forecast period.
Estrogen and progesterone are used in the treatment of female infertility. With its improved treatment therapies, the global market for estrogen and progesterone is expected to improve rapidly in the forecasted period. The global market for progesterone is driven by an increase in the spread of amenorrhea, which is anabsence of monthly periods. Looking towards, the demand for estrogen and progesterone, key market players are actively working on getting FDA approvals for their synthetic estrogen and progesterone to gain significant position in the estrogen and progesterone market. For instance, in December 2019, Drug firm Mankind Pharmalaunched its generic Dydrogesterone tablets for the treatment of infertility and pregnancy-related complications in the Indian market.
Further, in May 2019, Novartis announced that the company received approval for Piqray (alpelisib, formerly BYL719) the first and only treatment specifically for the treatment of postmenopausal women, and men.
(Get 15% Discount on Buying this Report)
Get Sample Copy of Estrogen and Progesterone Market at: https://orionmarketreports.com/request-sample/?id=92661&submit=Request+Sample%0D%0A
Market Coverage
•The market number available for - 2021-2028
•Base year- 2021
•Forecast period- 2022-2028
•Segment Covered-
•By Type
•By Application
•Regions Covered-
•North America
•Europe
•Asia-Pacific
•Rest of the World
Competitive Landscape-Bayer AG, Gedeon Richter Plc, N.V. Organon, Pfizer Inc., and Teva Pharmaceuticalsamong others.
A full report Estrogen and Progesterone Market of is available at: https://orionmarketreports.com/estrogen-and-progesterone-market/92661/
Global Estrogen and Progesterone Market Report by Segment
By Type
•Algepristone
•Mifepristone
•Asoprisnil
•Telapristone
•Ulipristal Acetate
By Application
•Pharmacy
•Hospital
•Department of Endocrinology
Key questions addressed by the report
•What is the market growth rate?
•Which segment and region dominate the market in the base year?
•Which segment and region will project the fastest growth in the market?
•How has COVID-19 impacted the market?
•Deviation from the pre-COVID-19 forecast
•Most affected region and segment
•Who is the leader in the market?
•How players are addressing challenges to sustain growth?
•Where is the investment opportunity?
Media Contact:
Company Name: Orion Market Reports
Contact Person: Mr. Anurag Tiwari
Email: info@orionmarketreports.com
Contact no: +91 780-304-0404
About Us:
Orion Market Reports (OMR) endeavors to provide exclusive blend of qualitative and quantitative market research reports to clients across the globe. Our organization helps both multinational and domestic enterprises to bolster their business by providing in-depth market insights and most reliable future market trends. Our reports address all the major aspects of the markets providing insights and market outlook to global clients.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Estrogen and Progesterone Market Trends, Business Overview, Industry Growth and Forecast to 2028 here
News-ID: 2586730 • Views: …
More Releases from Orion Market Research

AI-Enabled Imaging Modalities Market Rising Demand and Growth Forecast Through 2 …
AI-enabled imaging modalities market was valued at approximately USD 1.36 billion, and it is projected to reach around USD 19.78 billion by 2033, reflecting a compound annual growth rate (CAGR) of about 34.67% from 2024 to 2033.
AI-Enabled Imaging Modalities Market Overview
The AI-enabled imaging modalities market is experiencing rapid growth, driven by advancements in artificial intelligence and machine learning technologies. These innovations are enhancing the capabilities of various imaging modalities, including…

Tumor Tracking Systems Market Size Analysis, Competitive Insights, Leading Playe …
Global tumor tracking systems market was valued at approximately USD 3.5 billion, and it is projected to reach around USD 6.6 billion by 2033, reflecting a compound annual growth rate (CAGR) of about 5% from 2024 to 2033.
Tumor Tracking Systems Market Overview
The tumor tracking systems market is experiencing steady growth, driven by the increasing incidence of cancer and advancements in imaging and tracking technologies. These systems improve the precision of…

Tumor Tracking Systems Market Size Future Scope, Demands and Projected Industry …
Tumor tracking systems market was valued at approximately USD 3.5 billion, and it is projected to reach around USD 6.6 billion by 2033, reflecting a compound annual growth rate (CAGR) of about 5% from 2024 to 2033.
Tumor Tracking Systems Market Overview
The tumor tracking systems market is experiencing steady growth, driven by the increasing prevalence of cancer and advancements in imaging technologies. These systems play a crucial role in enhancing the…

SNP genotyping Market Size Analysis, Competitive Insights, Leading Players and G …
SNP genotyping market was valued at approximately USD 31.66 billion, and it is projected to reach around USD 238.25 billion by 2034, reflecting a compound annual growth rate (CAGR) of about 20.1% from 2024 to 2034.
SNP genotyping Market Overview
The SNP genotyping market is experiencing significant growth, driven by advancements in genotyping technologies, an increase in the prevalence of genetic disorders, and the expansion of pharmacogenomics and precision medicine initiatives. This…
More Releases for Estrogen
Estrogen Receptor Modulators Market Key Players, Share and Forecast Outlook
On April 29, 2025, Exactitude Consultancy., Ltd. released a research report titled "Estrogen Receptor Modulators Market". This report covers the global Estrogen Receptor Modulators market sales, sales volume, price, market share, ranking of major companies, etc., and provides a detailed analysis by region, country, product type, and application. It also forecasts the market size of automotive kick sensors based on market patterns from 2020 to 2034 and future market trends.…
Estrogen Receptor Modulators Market Key Players, Share and Forecast Outlook
On April 25, 2025, Exactitude Consultancy., Ltd. released a research report titled "Estrogen Receptor Modulators Market". This report covers the global Estrogen Receptor Modulators market sales, sales volume, price, market share, ranking of major companies, etc., and provides a detailed analysis by region, country, product type, and application. It also forecasts the market size of automotive kick sensors based on market patterns from 2020 to 2034 and future market trends.…
Advancements In Breast Cancer Treatment With Combination Treatment Of Estrogen B …
What industry-specific factors are fueling the growth of the estrogen blockers market?
The increasing occurrences of breast cancer are predicted to stimulate the development of the estrogen blocker market in the future. Breast cancer starts in the breast tissue, predominantly impacting the milk ducts and lobules. It transpires when there's a mutation in the breast cells, causing them to proliferate uncontrollably and create tumors. This cancer type's prevalence is climbing as…
How Artificial Intelligence is Shaping the Estrogen and Progesterone Market
Estrogen and Progesterone Market Revenue was valued at USD XX Billion in 2024 and is estimated to reach USD YY Billion by 2033, growing at a CAGR of ZZ% from 2026 to 2033.
Estrogen and Progesterone Market Future Scope
The Estrogen and Progesterone Market was valued at approximately USD 11.5 billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 6.8% from 2023 to 2030. The…
Emerging Estrogen Blockers Market Trend 2025-2034: Advancements In Breast Cancer …
How Is the Estrogen Blockers Market Projected to Grow, and What Is Its Market Size?
The market size for estrogen blockers has seen considerable growth in the past few years. The market worth will catapult from $9.35 billion in 2024 to $10.05 billion in 2025 with a compounded annual growth rate (CAGR) of 7.5%. The exponential growth in the preceding period can be traced back to an escalation in the occurrence…
Conjugated Estrogen Market Size, Industry Status and Forecast 2018-2028
Conjugated estrogen is an active pharmaceutical ingredient that contains a mixture of steroidal and non-steroidal components that are obtained from pregnant mares’ urine. Conjugated estrogen is used as an external source and is prescribed as a replacement of female natural hormones. Estrogen has many well-known effects on the tissues of the body. It causes the growth of the inner lining of uterus, secretion of cervix, development & growth of female…